Nearly 90,000 bottles of children’s ibuprofen oral suspension are being voluntarily recalled by Taro Pharmaceuticals U.S.A., Inc. Due to the potential presence of foreign matter, the Food and Drug Administration announced this week. The recall impacts a specific lot of the over-the-counter medication, commonly used to reduce fever and relieve pain in children, and underscores the importance of carefully checking medication before administering it to young ones.
The FDA received reports from consumers who discovered “a gel-like mass and black particles” within the bottles, prompting the voluntary recall. Even as the agency classifies this as a Class II recall – meaning the risk of serious adverse health consequences is considered remote – it’s a situation parents and caregivers should capture seriously. Understanding the details of this children’s ibuprofen recall, including which lots are affected and what steps to take, is crucial for protecting your family’s health.
What Products Are Affected?
The recall specifically affects four-ounce (120 ml) bottles of Children’s Ibuprofen Oral Suspension with lot codes 7261973A and 7261974A. These bottles also have an expiration date of January 31, 2027. The medication was manufactured in India for Taro Pharmaceuticals U.S.A., Inc., a subsidiary of Sun Pharma.
Bottles of children’s ibuprofen, made for Taro Pharmaceuticals U.S.A., Inc., are being recalled due to the potential presence of a foreign substance.
Ibuprofen is a widely used medication for children to manage pain and fever associated with common illnesses like colds, flu, sore throats, headaches, and toothaches. The FDA’s recall notice emphasizes that the affected product is an oral suspension, meaning it’s a liquid formulation designed for easy administration to children.
What is a Class II Recall?
The FDA categorizes recalls into three classes based on the level of health risk. A Class II recall, like this one, indicates that exposure to the affected product could cause temporary or medically reversible health consequences, or that the probability of serious adverse effects is low. This doesn’t mean the situation is without concern, but rather that the potential for significant harm is considered limited.
According to the FDA, Class I recalls pose the most risk, involving situations where the product could cause serious adverse health consequences or even death. Class III recalls are for products that are unlikely to cause any adverse health effects.
What is Taro Pharmaceuticals Saying?
Sun Pharma, the parent company of Taro Pharmaceuticals, released a statement addressing the recall. Jeremy Allen, vice president of corporate affairs for Sun Pharma, stated, “We are committed to maintaining the highest standards of quality across all Taro labeled products, including those manufactured by third-party partners such as Strides, the application holder. We are in close contact with Strides as it fully investigates the root cause of this issue and ensures all regulatory expectations are met. Sun Pharmaceuticals remains dedicated to protecting patient safety and ensuring strong oversight of our partner.”
Strides Pharma Science Limited is the company that originally applied for approval to market the ibuprofen suspension, according to the FDA recall notice. The investigation is focused on determining how the foreign particles entered the product during the manufacturing process.
What Should Parents Do?
The FDA advises consumers who have purchased the recalled Children’s Ibuprofen Oral Suspension to immediately stop using it. Do not administer the medication to your child. The agency recommends returning the product to the place of purchase for a refund or contacting Taro Pharmaceuticals directly for further instructions.
Consumers can also report any adverse events or quality problems experienced with the product to the FDA’s MedWatch Adverse Event Reporting program. This information helps the agency monitor product safety and identify potential issues.
Resources for Reporting and Information:
- FDA MedWatch: https://www.fda.gov/safety/medwatch
- Taro Pharmaceuticals: Contact information can be found on the FDA recall notice.
If your child has taken the recalled ibuprofen and you are concerned about their health, contact your pediatrician or seek medical attention. While the FDA considers the risk of serious harm to be low, it’s always best to err on the side of caution when it comes to children’s health.
This recall serves as a reminder of the importance of vigilance when administering medications, especially to children. Always check the lot number and expiration date, and carefully inspect the product for any signs of contamination before apply. Staying informed about drug recalls and following safety guidelines can help protect your family from potential health risks.
The FDA will continue to investigate the cause of the contamination and will provide updates as more information becomes available. Consumers can check the FDA website for the latest recall information and safety alerts. The next update from the FDA regarding this recall is expected within two weeks, as the investigation into the source of the contamination progresses.
Have questions or concerns about this recall? Share your thoughts in the comments below, and please share this information with other parents and caregivers.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
